Certain ethnicities have a higher prevalence and genetic risk for certain diseases over other and as such we have developed genetic risk assessment kits catering to the Jewish community.
Depending on your background, we offer two specialized kits for you and your family: one for Ashkenazi ancestry and a second one for Sephardic and Mizrahi ancestry.
Our kit is designed to assess 18 diseases predominant within Ashkenazi population. Approximately 1 in 4 individuals from the population is a carrier for one of the diseases, which means that the particular disease can be passed on to the next generation if the second parent is also a carrier. Our kit allows for screening of 17 such disorders which include Bloom Syndrome, Cystic Fibrosis, Canavan Disease, Favism, Familial dysautonomia, Familial hypercholesterolemia, Familial hyperinsulinism, Fanconi anemia C, Gaucher Disease, Glycogen storage disease type 1a, Haemophilia C, Mucolipidosis IV, Niemann-Pick type A, Nonclassical 21-hydroxylase deficiency, Tay Sachs, Torsion dystonia and Usher syndrome.
Our kit allows you to look at mutations on 17 different genes to assess your risk for these diseases.
Individuals from Ashkenazi Jewish ancestry also have higher incidence for breast and ovarian cancer. This can be added as an add-on the Ashkenazi ancestry disease risk assessment kit.
Individuals from Sephardic and Mizrahi ancestry have a higher risk for certain diseases compared to those from Ashkenazi ancestry and as such our kit is designed to assess 15 diseases predominant specifically within the Sephardic and Mizrahi communities. These include Ataxi telanglectasia, Beta-thalassemia, 11-beta-hydroxylase deficiency, Cerebrotendinous xanthomatosis, Creutzfeldt-Jakob disease, Cystinuria, Factor VII deficiency, Glucose-6-phosphate dehydrogenase deficiency, Glycogen Storage Disease III, Inclusion body myopathy, Limb girdle muscular dystrophy, Metachromatic leukodystrophy, Oculocutaneous albinism, Oculopharyngeal muscular dystrophy, Phenylketonuria and Tay Sachs.
A high proportion of individuals from the community are carriers for these diseases, which means that the particular disease can be passed on to the next generation if the second parent is also a carrier.
Familial Mediterranean Fever (FMF) also has a high prevalence amongst non-Ashkenazi Jewish populations. This can be added as an add-on to the Sephardic and Mizrahi ancestry disease risk assessment kit.